Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 8, 2005, Pages 896-900

  Swaminathan, Soumya ^a   Paramasivan, C N ^a   Ponnuraja, C ^a   Iliayas, S ^a   Rajasekaran, S ^b   Narayanan, P R ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b GOVERNMENT GENERAL HOSPITAL   (India)

Author keywords

Anti tuberculosis drug resistance; HIV; MDR TB; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; RIFATER; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPUTUM ANALYSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; HIV INFECTIONS; HUMANS; INDIA; PREVALENCE; PROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 23744511776     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Swaminathan S, Ramachandran R, Baskaran G, et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2000; 4: 839-844.
2. National AIDS Control Organisation. NACO website. New Delhi, India: NACO, Ministry of Health and Family Welfare, 2004. www.nacoonline.org Accessed December 2004.
3. Tripathy S P, Joshi D R, Mehendale S M, et al. Sentinel surveillance for HIV infection in tuberculosis patients in India. Indian J Tuberc 2002; 49: 17-20.
4. Jain N K, Aggarwal J K, Chopra K K, Khanna S P. Prevalence of HIV infection among tuberculosis patients. Indian J Tuberc 1996; 43: 105-107.
5. Ramachandran R, Datta M, Subramani R, Paramasivan C N, Swaminathan S. Seroprevalence of human immunodeficiency virus (HIV) infection among tuberculosis patients in Tamil Nadu. Indian J Med Res 2003; 118: 147-151.
6. Khatri G R, Frieden T R. Controlling tuberculosis in India. N Engl J Med 2002; 347: 1420-1425.
7. Central TB Division. RNTCP in India. New Delhi, India: Central TB Division, Directorate General of Health Services, May 2004: pp 17-24.
8. Yoshiyama T, Supawitkul S, Kunyanone N, et al. Prevalence of drug-resistant tuberculosis in an HIV endemic area of northern Thailand. Int J Tuberc Lung Dis 2001; 5: 32-33.
9. Kenyon T A, Mwasekaga M J, Huebner R, Rumisha D, Binkin N, Maganu E. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis 1999; 3: 4-11.
10. Punnotok J, Shaffer N, Naiwatanakul T, et al. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. Int J Tuberc Lung Dis 2000; 4: 537-543.
11. Birdi T Z, Dholakia Y, D'Souza D T B, Oza B B, Hira S, Antia N H. A preliminary report on initial mycobacterial drug resistance in HIV-TB dual infection in Mumbai. Brit Med J 2002; 18: 879-881.
12. Allen B, Baker R J. Mycobacteria: isolation, identification and sensitivity testing. London UK: Butterworth, 1968.
13. Kubica, G P. Differential identification of mycobacteria, VII. Key to features for identification of clinically significant mycobacteria. Am Rev Respir Dis 1973; 107: 9-21.
14. Tuberculosis Chemotherapy Centre, Madras. A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India. Bull World Health Organ 1960; 23: 535-585.
15. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programs. Bull World Health Organ 1969; 41: 21-43.
16. Frieden T R, Sterling T, Pablos-Mendez A, Billburn J O, Cauthen G M, Dooley S W. The emergence of drug resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
17. Ritaco V, di Lonardo M, Reniero A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 1997; 176: 637-642.
18. Frieden T R, Sherman L S, Maw K L, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. JAMA 1996; 276: 1229-1235.
19. Edlin B R, Tokars J I, Grieco M H, et al. An outbreak of multidrug resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
20. Anastasis D, Pillai G G, Rambiritch S, Karim S S A. A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 1997; 1: 220-224.
21. MacArthur A, Gloyd S, Perdigano P, Noya A, Sacarlal J, Kreiss J. Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int J Tuberc Lung Dis 2001; 5: 894-902.
22. Paramasivan C N, Bhaskaran K, Venkataraman P, et al. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuberc 2000; 47: 27-33.
23. Paramasivan C N, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan P R. Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Lung Dis 2002; 6: 479-484.
24. Bruchfeld J, Aderaye G, Palme I B, et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol 2002; 40: 1636-1643.
25. Datta M, Radhamani M P, Selvaraj R, et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tubercle Lung Dis 1993; 74: 180-186.
26. Vernon A, Burman W, Benator D, Khan A, Bozeman L. Acquired monoresistance in patients with HIV related tuberculosis treated with once weekly rifapentine and isoniazid. Lancet 1999; 353: 1843-1847.
27. Patel K B, Belmonte R, Crowe H M. Drug malabsorption and resistant tuberculosis in HIV-infected patients. N Engl J Med 1995; 332: 336-337.
28. Gurumurthy P, Ramachandran G, Hemanth Kumar A K, et al. Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis. Clin Infect Dis 2004; 38: 280-283.